Ranbaxy, Gilead, Mylan, Strides Join To Push HIV In Developing Nations
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy and three global drug makers have joined with Gilead to speed availability of its Emtriva (emtricitabine) HIV treatment for developing countries.